Find out more

EMCDDA publications

Cannabis legislation in Europe: an overview.
Country Drug Reports 2017.
Drug trafficking penalties across the European Union: a survey of expert opinion, Technical reports.
Cocaine trafficking to Europe, Perspectives on Drugs.
Changes in Europe’s cannabis resin market, Perspectives on Drugs.
Internet and drug markets, Insights.
Opioid trafficking routes from Asia to Europe, Perspectives on Drugs.
New psychoactive substances in Europe. An update from the EU Early Warning System, Technical reports.
The internet and drug markets, Technical reports.
New developments in Europe’s cannabis markets, Perspectives on Drugs.
Drug supply reduction and internal security, EMCDDA Papers.
Legal approaches to controlling new psychoactive substances, Perspectives on Drugs.
Models for the legal supply of cannabis: recent developments, Perspectives on Drugs.
Synthetic cannabinoids in Europe, Perspectives on Drugs.
Synthetic drug production in Europe, Perspectives on Drugs.
Cannabis production and markets in Europe, Insights.

EMCDDA and Europol joint publications

EMCDDA–Europol Joint Report on a new psychoactive substance: acryloylfentanyl, Joint Reports.
EU Drug Markets Report: In-depth Analysis.
EU Drug Markets Report: Strategic Overview.
EMCDDA–Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA.
EMCDDA–Europol Joint Report on MDMB-CHMICA, Joint Reports.
EMCDDA–Europol Joint Report on acetylfentanyl, Joint Reports.
EMCDDA–Europol Joint Report on a new psychoactive substance: α-PVP, Joint Reports.
Amphetamine: a European Union perspective in the global context.

EMCDDA and Eurojust joint publications

New psychoactive substances in Europe: legislation and prosecution - current challenges and solutions.

All publications are available at